SciGene
Private Company
Total funding raised: $500K
Overview
SciGene is a specialized provider of automation and consumable solutions for the cytogenetics and molecular pathology markets. The company's core value proposition lies in offering integrated systems like the Scorpion robot, MicroFISH system, and Little Dipper processor that streamline labor-intensive manual processes in diagnostic labs. By focusing on workflow automation and assay reliability, SciGene addresses key pain points of cost, reproducibility, and technician time in cytogenetics. Its business model is built on selling capital equipment, proprietary consumables, and reagents directly to laboratories and through a global distributor network.
Technology Platform
Integrated hardware and chemistry systems for automating cytogenetic laboratory workflows, including automated slide processors, hybridizers, incubators, and proprietary reagents for FISH and karyotyping.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
SciGene competes in the niche cytogenetics automation market against larger players like Abbott Molecular, Agilent, and Leica Biosystems, which offer broader diagnostic platforms. Its competitive advantage lies in specialized, integrated systems and deep expertise in FISH workflow optimization, targeting labs seeking dedicated, cost-effective solutions.